Strong Revenue Growth
Sartorius reported a revenue growth of 6% in constant currencies, driven by a strong increase in consumables sales. The Bioprocessing Solutions sales revenue grew by nearly 9% year-over-year on a constant currency basis.
Increased Profitability
The underlying EBITDA increased by 12% year-over-year, with the EBITDA margin approaching 30%. This margin expansion was driven by positive volume, product mix, and economies of scale.
Launch of New Products
Introduced new products in both bioprocessing and lab divisions, including a platform for incentivized bioprocesses and the new model of IncuCyte for real-time cell observation.
Confirmation of Full-Year Guidance
The company confirmed its full-year 2025 guidance, indicating confidence in meeting revenue and EBITDA margin targets.